LFKRI Seminar Series

2018 Seminars

Thursday, October 18, 2018 - 11AM
“In vitro studies of erythropoiesis”
Ashley Toye, PhD
Principal Investigator, UK NHS-Blood & Transplant, and Senior Lecturer in Erythrocyte Biology, Department of Biochemistry, University of Bristol, UK

Thursday, October 11, 2018 - 11AM
“Thrombopoietic Agents in 2018: Ten Years Later”
James Bussel, MD
Professor Emeritus of Pediatrics, Weill Cornell Medical School, New York

Thursday, October 4, 2018 - 11AM
“Exploring the role of TAM (Tyro3_Axl_Mertk) receptors as a novel innate immune checkpoint in cancer immunotherapy" 
Hind Medyouf, PhD
Group Leader, Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt am Main, Germany

Thursday, September 13, 2018 - 11:30AM
"Blood Center Considerations for Cellular Product Collections and Distribution"
Robert J. Tressler PhD
Vice President of Laboratories at San Diego Blood Bank

Thursday, September 6, 2018 - 11AM
“Modeling HIV pathogenesis, prevention and novel  therapies in humanized mice
Ramesh Akkina, DVM, PhD
Professor, Department of Microbiology, Immunology and Pathology, Colorado State University

Wednesday, August 29, 2018 - 1PM
"Setting up biobanks and translation research services in academia; experiences and challenges"
Hassana Fathallah, PhD
Director, Clinical Trials Scientific Affairs, ACM Global Laboratories, Rochester, New York

WEDNESDAY, AUGUST 22, 2018 - 1PM
“The role of CDMO's in the commercialization of cell therapy"
Ruud Hulspas, PhD
Founder, Cellular Technologies Bio-consulting, LLC, Rockville, MD 

MONDAY, JULY 9, 2018 - 11AM
"Pulmonary Inflammation in Sickle Cell Disease"
Jeffrey A. Glassberg, M.D.
Associate Professor of Hematology and Medical Oncology, and Emergency Medicine, Mount Sinai School of Medicine, New York

THURSDAY, JUNE 14, 2018 - 11AM
“Apheresis Collection for T cell Manufacturing: What’s in the bag and why do we care?”

Andrew D. Fesnak, MD
Assistant Professor, Director, Manufacturing, Clinical Cell and Vaccine Production Facility, University of Pennsylvania

FRIDAY, APRIL 20, 2018 - 12PM
"Patient Blood Management in Sickle Cell Disease"
France Pirenne, MD, PhD
Medical and Scientific Director, Etablissement Français du Sang, Créteil, Professor of Hematology, Institut Mondor de Recherche Biomédicale, lNSERM

FRIDAY, MARCH 30, 2018 - 11AM 
"Barriers and Facilitators to Potential Future Biomedical HIV Prevention Products in Transgender and Cisgender Women" 
Christine Rael, PhD
Postdoctoral Research Fellow, HIV Center for Clinical and Behavioral Studies, Columbia University

THURSDAY, FEBRUARY 22, 2018 - 11AM
"Role of Tissue Factor in Hemostasis, Thrombosis and Viral Infections"
Nigel Mackman, PhD, FAHA
John C. Parker
Distinguished Professor of Medicine, Co-Director of the Thrombosis and Hemostasis Program, University of North Carolina at Chapel Hill

2017 Seminars

MONDAY, DECEMBER 4, 2017 - 11AM
"Armored Chimeric Antigen Receptor (CAR) T Cells for Solid Tumor Malignancies"

Oladapo Yeku, MD, PhD
Medical Oncology Fellow, Memorial Sloan Kettering Cancer Center

THURSDAY, NOVEMBER 30, 2017 - 11AM
"Type 1 Interferons Promote Alloimmune Responses to Transfused RBC Antigens"
David Gibbs, MD, PhD
Transfusion Medicine/Blood Bank Fellow, Department of Laboratory Medicine, Yale University

TUESDAY, NOVEMBER 28, 2017 - 11AM
"Stem Cell-Derived Megakaryocytes Tool for Translational Research and Source of Cellular Therapies"

Camelia Iancu-Rubin, PhD
Associate Professor, Scientific Director, Hematological Malignancies Tissue Bank, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai

MONDAY, NOVEMER 20, 2017 - 11AM
"Investigations into the AML Cell Surfaceome"

Fabiana Perna, MD, PhD
Senior Research Scientist, Memorial Sloan Kettering Cancer Center, New York

THURSDAY, November 16, 2017 - 11AM
"Insights into Immune Defects in Rag-deficiency and Stem Cell Collections for Gene Therapy in Sickle Cell Anemia"

John Manis, MD
Associate Director of Transfusion Medicine, Boston Children's Hospital, Harvard Medical School

THURSDAY, OCTOBER 12, 2017 - 11AM
"Heterogeneity Assays and Platelet Lysate: Challenges and Chances for Stem Cell Therapies Development"

Richard Schaefer, MD
Head of Department Cell Therapeutics & Cell Processing, German Red Cross, Goethe-University Hospital, Frankfurt, Germany

THURSDAY, SEPTEMBER 7, 2017 - 11AM
"Exploring the Human Microbiome"

Tao Ding, PhD
Postdoctoral Researcher, Department of Biology, Center for Genomics and Systems Biology, New York University

MONDAY, AUGUST 21, 2017 - 11AM
"Inflammasomes and Danger Signals during Infection by Intracellular Pathogens"
David M. Ojcius, PhD
Professor and Chair, Department of Biomedical Sciences, University of the Pacific,Arthur A. Dugoni School of Dentistry

MONDAY, JULY 24, 2017 - 2PM
"Inflammatory Modulation of the Bone Marrow Hematopoietic Niche"
Leslie E. Silberstein, MD
Director, Joint Program in Transfusion Medicine, Professor, Harvard Medical School

THURSDAY, JULY 20, 2017 - 11AM
"Dickkopf-1: The Wnt Antagonist Becomes a Novel Immunomodulator"
Wook-Jin Chae, PhD
Associate Research Scientist, Department of Immunobiology, Yale University School of Medicine

MONDAY, JULY 17, 2017 - 1PM
“Making Platelets In Vitro from Pluripotent Stem Cells: Going Beyond Transfusion and Blood Clotting”
Cedric Ghevaert, MD, PhD
Consultant Hematologist, Senior Lecturer in Transfusion Medicine, Department of Hematology, University of Cambridge, UK

THURSDAY, MAY 18, 2017 - 11AM
“The Mechanism of Action of Anti-D in Preventing Hemolytic Disease of the Fetus and Newborn: What Do We Really Know?”
Alan H. Lazarus, PhD
Scientist, St. Michael's Hospital and Canadian Blood Services, Professor of Medicine, University of Toronto

WEDNESDAY, APRIL 5, 2017 - 1PM
“Genetics and Metabolomics of Blood Storage”
James C. Zimring, MD, PhD
Director and Chief Scientific Officer, BloodworksNW Research Institute, Professor, Department of Lab Medicine and Department of Medicine, University of Washington School of Medicine

THURSDAY, MARCH 2, 2017 - 11AM
“Insights into ZIKV Epidemiology, Diagnostics and Pathogenesis from Studies of Blood Donors and Recipients”

Michael Busch, MD, PhD
Director and VP, Research and Scientific Affairs, Blood Systems Research Institute

THURSDAY, FEBRUARY 16, 2017 - 11AM
“Engineering of Complex Tissues - New Possibilities for Drug Development and Regenerative Medicine”
Jan Hansmann, PhD
Group Leader, University Hospital of Würzburg, Fraunhofer Institute of Interfacial Engineering and Biotechnology

Want more information?

Email: TDeVard@nybloodcenter.org
Office: (212) 570-3136